| Literature DB >> 24711900 |
Andreia Henriques1, Regina Arantes-Rodrigues1, Ana I Faustino-Rocha1, Catarina I Teixeira-Guedes1, Jacinta Pinho-Oliveira1, Daniela Talhada1, José H Teixeira1, Andreia Andrade1, Bruno Colaço2, Maria N Paiva-Cardoso1, Maria J Pires3, Ana Mvd Ferreira4, Fernando M Nunes4, Paula A Oliveira3.
Abstract
OBJECTIVE(S): Green tea (GT) is one of the most popular beverages worldwide whose beneficial effects on health have been demonstrated. Recent studies suggest that GT may contribute to reduction of cancer risk and progression. The aim of this study was to evaluate the effects of whole GT on urinary bladder chemical carcinogenesis in male and female ICR mice.Entities:
Keywords: Green tea; Mice; N-butyl-N-(4-hydroxybutyl)nitro- samine; Urinary bladder cancer
Year: 2014 PMID: 24711900 PMCID: PMC3976754
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Green tea chemical characterization
| Sample | Total phenols | Flavonoids | Antioxidant capacity | |||
|---|---|---|---|---|---|---|
| mg GA/ 100 g of infusion | mg GA/ 100 g of GT leaves | mg Qr/ 100 g of infusion | mg Qr/ 100 g of GT leaves | mg Tx/ 100 g of infusion | mg Tx/ 100 g of GT leaves | |
| S1 | 34.80 | 69.64 | 3.53 | 7.07 | 193.18 | 386.36 |
| S2 | 36.40 | 72.81 | 2.84 | 5.69 | 183.72 | 367.44 |
| S3 | 34.50 | 69.03 | 2.82 | 5.65 | 201.92 | 403.85 |
| M±SD | 35.23±1.02 | 70.49±2.03 | 3.06±0.40 | 6.13±0.81 | 192.94±9.10 | 385.88±18.2 |
S- Sample; GA- Gallic acid; Qr- Quercetin; Tx- Trolox; Mean±SD
Urothelium histopathological evaluation n (%) and inflammatory aggregates (mean±standard deviation)
| Groups | Male | Female | |||||
|---|---|---|---|---|---|---|---|
| Microscopic analysis | I (n=8) | II (n=6) | III (n=6) | IV (n=7) | V (n=6) | VI (n=6) | |
| Histological | Normal urothelium | 0 (0%) | 0 (0%) | 6 (100%) | 0 (0%) | 0 (0%) | 6 (100%) |
| Simple hyperplasia | 6 (75%) | 3 (50%) | 0 (0%) | 3 (42.8%) | 4 (66.7%) | 0 (0%) | |
| Dysplasia | 7 (87.5%) | 5 (83.3%) | 0 (0%) | 4 (57.1%) | 4 (66.7%) | 0 (0%) | |
| Papilloma | 2 (25%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |
| Squamous metaplasia | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (16.7%) | 0 (0%) | |
| Inflammatory aggregates | 3.50±4.46 | 4.67±2.99a | 0.42±0.90 | 3.50±2.56 | 3.83±3.13b | 0.25±0.45 | |
a P < 0.05 versus Group III; b P < 0.05 versus Group VI